Novartis Investigative Site

Blagoevgrad, Bulgaria 2700

0 studies enrolling now · 1 studies all time

What they study most

Cardiovascular Disease and Lipoprotein(a)

Studies at this site

• Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD — Running, not enrolling